JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2025, 74(4):258-262 | DOI: 10.36290/csf.2025.042

Bioactive compounds with adjuvant therapeutic potential in neurodegenerative diseases and peripheral neuropathy

Alice Sychrová
Phyto Consulting, Brno

Introduction: Neurodegenerative diseases and peripheral neuropathies share several common pathophysiological mechanisms, including oxidative stress, neuroinflammation, and mitochondrial dysfunction. Although their clinical manifestations differ, similar neuroprotective therapeutic approaches are applied in both conditions.

Aim: The aim of this review is to summarize current knowledge on the use of nutraceuticals and vitamin supplementation as adjuvant strategies in the prevention and treatment of neurodegenerative diseases and peripheral neuropathies.

Methods: The literature review focused on studies evaluating the efficacy, mechanisms of action, safety aspects, and recommended dosages of selected bioactive compounds, including antioxidants, phospholipids, nucleosides, polyphenols, and vitamins.

Results: Available clinical and experimental evidence indicates a beneficial effect of several nutraceuticals on oxidative stress, inflammatory response, and mitochondrial function, which may contribute to slowing disease progression and improving peripheral nerve function.

Conclusion: Nutraceuticals represent a promising adjunct to conventional therapy for neurodegenerative diseases and peripheral neuropathies. However, further clinical studies are needed to confirm their efficacy, standardize dosing, and assess long-term safety.

Keywords: amino acids, antioxidants, phospholipids, neurodegenerative diseases, neurotropic vitamins, peripheral neuropathy.

Accepted: November 21, 2025; Published: December 5, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sychrová A. Bioactive compounds with adjuvant therapeutic potential in neurodegenerative diseases and peripheral neuropathy. Čes. slov. farm. 2025;74(4):258-262. doi: 10.36290/csf.2025.042.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 60 CZK (2.5 EUR)
    will be unlocked 5.12.2026

    References

    1. Rekatsina M, Paladini A, Piroli A, et al. Pathophysiology and Therapeutic Perspectives of Oxidative Stress and Neurodegenerative Diseases: A Narrative Review. Adv Ther. 2020;37(1):113-139. Go to original source... Go to PubMed...
    2. Franco GA, Interdonato L, Cordaro M, et al. Bioactive compounds of the Mediterranean diet as nutritional support to fight neurodegenerative disease. Int J Mol Sci. 2023;24(8):7318. Go to original source... Go to PubMed...
    3. Hammi C, Yeung B. Neuropathy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. [cited 2025 Jul 4]. Available from: https://www.ncbi.nlm.nih.gov/sites/books/NBK542220/.
    4. Hersant H, He S, Maliha P, et al. Over the Counter Supplements for Memory: A Review of Available Evidence. CNS Drugs. 2023;37:797-817. Go to original source... Go to PubMed...
    5. Di Stefano G, Di Lionardo A, Galosi E, et al. Acetyl-L-carnitine in painful peripheral neuropathy: a systematic review. J Pain Res. 2019;12:1341-1351. Go to original source... Go to PubMed...
    6. Teleanu RI, Chircov C, Grumezescu AM, et al. Antioxidant therapies for neuroprotection-a review. J Clin Med. 2019;8(10):1659. Go to original source... Go to PubMed...
    7. Cichon N, Dziedzic A, Gorniak L, et al. Unusual bioactive compounds with antioxidant properties in adjuvant therapy supporting cognition impairment in age-related neurodegenerative disorders. Int J Mol Sci. 2021;22(19):10707. Go to original source... Go to PubMed...
    8. Mantle D, Hargreaves I. Coenzyme Q10 and the blood-brain barrier: An overview. J Clin Med. 2025;14(8):2748. Go to original source... Go to PubMed...
    9. Fakhrabadi MA, Ghotrom AZ, Mozaffari-Khosravi H, et al. Effect of coenzyme Q10 on oxidative stress, glycemic control and inflammation in diabetic neuropathy: a double blind randomized clinical trial. Int J Vitam Nutr Res. 2014;84(5-6):252-260. Go to original source... Go to PubMed...
    10. Amini P, Sajedi F, Mirjalili M, et al. Coenzyme Q10 as a potential add on treatment for patients suffering from painful diabetic neuropathy: Results of a placebo controlled randomized trial. Eur J Clin Pharmacol. 2022;78(12):1899-1910. Go to original source... Go to PubMed...
    11. Nosková P. Kyselina alfa-lipoová a její místo v léčbě neuropatické bolesti. Neurol pr prakt. 2020;21(1):50-52. Go to original source...
    12. Shinto L, Quinn J, Montine T, et al. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. J Alzheimers Dis. 2014;38(1):111-120. Go to original source... Go to PubMed...
    13. Abubaker SA, Alonazy AM, Abdulrahman A. Effect of alpha lipoic acid in the treatment of diabetic neuropathy: A systematic review. Cureus. 2022;14(6):e25750. Go to original source... Go to PubMed...
    14. Baicus C, Purcarea A, von Elm E, et al. Alpha-lipoic acid for diabetic peripheral neuropathy. Cochrane Database Syst Rev. 2024;1:CD012967. Go to original source... Go to PubMed...
    15. Pekdemir B, Raposo A, Saraiva A, et al. Mechanisms and Potential Benefits of Neuroprotective Agents in Neurological Health. Nutrients. 2024;16(24):4368. Go to original source... Go to PubMed...
    16. Asadi S, Gholami MS, Siassi F, et al. Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled clinical trial. Complement Ther Med. 2019;43:253-260. Go to original source... Go to PubMed...
    17. Bahramsoltani R, Rahimi R, Farzaei MH. Pharmacokinetic interactions of curcuminoids with conventional drugs: A review. J Ethnopharmacol. 2017;209:1-12. Go to original source... Go to PubMed...
    18. Wang W, Li J, Zhang H, et al. Effects of vitamin E supplementation on the risk and progression of AD: a systematic review and meta-analysis. Nutr Neurosci. 2021;24(1):13-22. Go to original source... Go to PubMed...
    19. Chen J, Shan H, Yang W, et al. Vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis. Front Pharmacol. 2021;12:684550. Go to original source... Go to PubMed...
    20. Miller ER 3rd, Pastor-Barriuso R, Dalal D, et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142(1):37-46. Go to original source... Go to PubMed...
    21. Jasielski P, Piędel F, Piwek M, et al. Application of citicoline in neurological disorders: a systematic review. Nutrients. 2020;12(10):3113. Go to original source... Go to PubMed...
    22. Pereira ME, Souza JV, Galiciolli MEA, et al. Effects of Selenium Supplementation in Patients with Mild Cognitive Impairment or Alzheimer's Disease: A Systematic Review and Meta-Analysis. Nutrients. 2022;14(15):3205. Go to original source... Go to PubMed...
    23. Zhou J, Zhang W, Cao Z, et al. Association of selenium levels with neurodegenerative disease: a systemic review and meta-analysis. Nutrients. 2023;15(17):3706. Go to original source... Go to PubMed...
    24. Calderón-Ospina CA, Nava-Mesa MO. B vitamins in the nervous system: current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin. CNS Neurosci Ther. 2020;26(1):5-13. Go to original source... Go to PubMed...
    25. Jolivalt CG, Mizisin LM, Nelson A, et al. B vitamins alleviate indices of neuropathic pain in diabetic rats. Eur J Pharmacol. 2009;612(1-3):41-47. Go to original source... Go to PubMed...
    26. Hakim M, Kurniani N, Pinzon RT, et al. Management of peripheral neuropathy symptoms with a fixed dose combination of high-dose vitamin B1, B6 and B12: A 12-week prospective non-interventional study in Indonesia. Asian J Med Sci. 2018;9(1):32-40. Go to original source...
    27. Martel JL, Kerndt CC, Doshi H, et al. Vitamin B1 (Thiamine) [Internet]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. [cited 2025 Jul 4]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482360/
    28. Office of Dietary Supplements, National Institutes of Health. Vitamin B1, B6, B9 a B12 - Factsheets for Health Professionals [Internet]. Bethesda (MD): NIH; c2022-2025 [cited 2025 Jul 4]. Available from: https://ods.od.nih.gov/.
    29. Baumel BS, Doraiswamy PM, Sabbagh M, et al. Potential neuroregenerative and neuroprotective effects of uridine/choline-enriched multinutrient dietary intervention for mild cognitive impairment: a narrative review. Neurol Ther. 2021;10(1):43-60. Go to original source... Go to PubMed...
    30. Wurtman RJ, Cansev M, Sakamoto T, et al. Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses. Nutr Rev. 2010;68 Suppl 2(Suppl 2):S88-101. Go to original source... Go to PubMed...
    31. Yang Y, Ye Y, Deng Y, et al. Uridine and its role in metabolic diseases, tumors, and neurodegenerative diseases. Front Physiol. 2024;15:1360891. Go to original source... Go to PubMed...
    32. Goldberg H, Mibielli MA, Nunes CP, et al. A double-blind, randomized, comparative study of the use of a combination of uridine triphosphate trisodium, cytidine monophosphate disodium, and hydroxocobalamin, versus isolated treatment with hydroxocobalamin, in patients presenting with compressive neuralgias. J Pain Res. 2017;10:397-404. Go to original source... Go to PubMed...

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.